Delivery Order SPE2DB24D1007-SPE2DB24FBZHC
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a delivery order contract valued at $3,518.40 for the supply of NUBEQA 300 MG TABLET 120S. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $3,518.40 Delivery Order is for the supply of the prescription drug NUBEQA 300 MG TABLET 120S. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA through December 2025, which serves as the primary vehicle for the company to provide a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, Pennsylvania. The $7,280.00 firm fixed price delivery order is for the supply of 120 tablets of the drug NUBEQA 300 MG. The contract has an ultimate completion date of June 30, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a $9,367.94 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565941321 - NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a period of performance through October 17, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order (DO) valued at $7,036.80 for the supply of the pharmaceutical product NUBEQA 300 MG TABLET 120S. The contract has a completion date of July 22, 2024 and was awarded on June 28, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued...
- This is a $14,051.91 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of NUBEQA 300 MG TABLET 120S, a pharmaceutical product. This order is placed under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which Amerisourcebergen holds with the DLA Troop Support Medical for delivering a range of medical commodities to support...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $3,518.40 contract is for the delivery of 120 tablets of the pharmaceutical product NUBEQA 300 MG to support U.S. military treatment programs and facilities. This order is issued under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of pharmaceutical products, including the prescription drug NUBEQA 300 MG TABLET 120S, to the Defense Logistics Agency (DLA). The $3,518.40 firm fixed-price delivery order has a completion date of July 11, 2024 and is not designated as a set-aside contract. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, holds a significant Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $10,555.20 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. This contract is for the provision of 120 tablets of the drug NUBEQA 300 MG, with a completion date of March 4, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor on this delivery order...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of the prescription drug NUBEQA 300 MG TABLET 120S to federal government agencies. The contract, valued at $4,683.97, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of December 10, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- SPE2DB24D1007Indefinite Delivery Contract
- SPE2DB24D1007-SPE2DB24FBZHCDelivery Order
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $3,518.40 to Amerisourcebergen Drug Corp's Corporate Office Division. This contract, which has a ceiling value of $3,518.40 and a completion date of May 24, 2024, is for the provision of the pharmaceutical product NUBEQA 300 MG TABLET 120S. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the federal government, with a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 5/3/24 |